Complete Occlusion of Coilable Aneurysms



Status:Completed
Conditions:Cardiology, Neurology
Therapuetic Areas:Cardiology / Vascular Diseases, Neurology
Healthy:No
Age Range:21 - 75
Updated:4/21/2016
Start Date:October 2008
End Date:April 2015

Use our guide to learn which trials are right for you!

To compare the safety and effectiveness of Pipeline Embolization Device to coil embolization
for the treatment of coilable wide-necked intracranial aneurysms


Inclusion Criteria:

- Age 21 to 75 years, inclusive

- Patient has a single target IA that:

1. is located in the following regions of the internal carotid artery: i.
Paraophthalmic (including paraclinoid, ophthalmic and hypophyseal segments) ii.
Cavernous iii. Petrous

2. is saccular

3. has a parent vessel with diameter 2.5-5.0 mm

- If target IA has a neck >4 mm, at least 2 of 3 members of an independent expert
committee (IEC) have confirmed that coil embolization with optional adjunctive
techniques** has a very high likelihood of procedural success (i.e., coil placement
and retention)

- Subject has provided written informed consent using the IRB-approved consent form

- Subject has the necessary mental capacity to participate and is willing and able to
comply with protocol requirements

- ** Adjunctive techniques include intravascular balloons ["balloon remodeling"],
3D coils, dual catheter techniques.

Exclusion Criteria:

- Target IA has BOTH neck >4 mm AND size (maximum fundus diameter) >10 mm

- More than one IA requires treatment in the next 6 months

- Subarachnoid hemorrhage in the past 60 days

- Any intracranial hemorrhage in the last 42 days

- Major surgery in the last 42 days

- Coils in place in the target IA

- Unstable neurologic deficit (i.e., any worsening of clinical condition in the last 30
days)

- Known irreversible bleeding disorder

- Platelet count < 100 x 103 cells/mm3 or known platelet dysfunction

- Inability to tolerate, documented evidence of adverse reaction or contraindication to
study medications

- Prior stent placement at target site

- Contraindication to CT scan AND MRI

- Known allergy to contrast used in angiography that cannot be medically controlled

- Known severe allergy to platinum or cobalt/chromium alloys

- Relative contraindication to angiography (e.g., serum creatinine > 2.5 mg/dL)

- Woman of child-bearing potential who cannot provide a negative pregnancy test

- Evidence of active infection at the time of treatment

- Other known conditions of the heart, blood, brain or intracranial vessels that carry
a high risk of neurologic events (e.g., severe heart failure, atrial fibrillation,
known carotid stenosis)

- Current use of cocaine or other illicit substance

- Any comorbid disease or condition expected to compromise survival or ability to
complete follow-up assessments to 180 days

- Extracranial stenosis greater than 50% in the carotid artery

- Intracranial stenosis greater than 50% in the treated vessel
We found this trial at
2
sites
Stony Brook, New York 11794
?
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Phoenix, Arizona 85013
?
mi
from
Phoenix, AZ
Click here to add this to my saved trials